65 related articles for article (PubMed ID: 10502435)
1. Differences in K-ras codon 12 mutation frequency between "high-risk" and "low-risk" HPV-infected samples.
Golijow CD; Mourón SA; Gómez MA; Dulout FN
Gynecol Oncol; 1999 Oct; 75(1):108-12. PubMed ID: 10502435
[TBL] [Abstract][Full Text] [Related]
2. "Low-risk" and "high-risk" HPV-infection and K-ras gene point mutations in human cervical cancer: a study of 31 cases.
Stenzel A; Semczuk A; Rózyńskal K; Jakowicki J; Wojcierowski J
Pathol Res Pract; 2001; 197(9):597-603. PubMed ID: 11569923
[TBL] [Abstract][Full Text] [Related]
3. [Analysis of prevalence of point mutations in codon 12 of oncogene K-ras from non-cancerous samples of cervical cytology positive for type 16 or 18 PVH].
Golijow CD; Mourón SA; Gómez MA; Dulout FN
Invest Clin; 1999 Dec; 40(4):257-66. PubMed ID: 10666952
[TBL] [Abstract][Full Text] [Related]
4. [Ha-ras and p53 gene mutations scanned by PCR-SSCP in premalignant and malignant lesions of the uterine cervix associated with human papillomavirus].
Alonio LV; Dalbert D; Picconi MA; Cervantes Vazquez G; García Carrancá A; Distefano AL; Mural J; Bartt O; Bazan G; Teyssie AR
Medicina (B Aires); 2000; 60(6):895-901. PubMed ID: 11436698
[TBL] [Abstract][Full Text] [Related]
5. Relationships between c-Ki-ras mutations, HPV types, and prognostic indicators in invasive endocervical adenocarcinomas.
Koulos JP; Wright TC; Mitchell MF; Silva E; Atkinson EN; Richart RM
Gynecol Oncol; 1993 Mar; 48(3):364-9. PubMed ID: 8385060
[TBL] [Abstract][Full Text] [Related]
6. Presence of ras oncogene mutations and human papillomavirus DNA in human prostate carcinomas.
Anwar K; Nakakuki K; Shiraishi T; Naiki H; Yatani R; Inuzuka M
Cancer Res; 1992 Nov; 52(21):5991-6. PubMed ID: 1382850
[TBL] [Abstract][Full Text] [Related]
7. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis.
Wang-Johanning F; Lu DW; Wang Y; Johnson MR; Johanning GL
Cancer; 2002 Apr; 94(8):2199-210. PubMed ID: 12001118
[TBL] [Abstract][Full Text] [Related]
8. [Detection and typing of human papilloma virus by polymerase chain reaction and hybridization assay in cervical samples with cytological abnormalities].
Ergünay K; Misirlioğlu M; Firat P; Tuncer ZS; Tuncer S; Yildiz I; Ustaçelebi S
Mikrobiyol Bul; 2008 Apr; 42(2):273-82. PubMed ID: 18697425
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus and mutated H-ras oncogene in cervical carcinomas and pathological negative pelvic lymph nodes: a retrospective follow-up.
Landro ME; Dalbert D; Picconi MA; Cúneo N; González J; Vornetti S; Bazán G; Mural J; Basiletti J; Teyssié AR; Alonio LV
J Med Virol; 2008 Apr; 80(4):694-701. PubMed ID: 18297710
[TBL] [Abstract][Full Text] [Related]
10. Low incidence of HPV DNA in sera of pretreatment cervical cancer patients.
Liu VW; Tsang P; Yip A; Ng TY; Wong LC; Ngan HY
Gynecol Oncol; 2001 Aug; 82(2):269-72. PubMed ID: 11531278
[TBL] [Abstract][Full Text] [Related]
11. Lack of synergistic association between human papillomavirus and ras gene point mutation in laryngeal carcinomas.
Shidara K; Suzuki T; Hara F; Nakajima T
Laryngoscope; 1994 Aug; 104(8 Pt 1):1008-12. PubMed ID: 8052064
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus DNA in urine samples of women with or without cervical cancer and their male partners compared with simultaneously collected cervical/penile smear or biopsy specimens.
Gupta A; Arora R; Gupta S; Prusty BK; Kailash U; Batra S; Das BC
J Clin Virol; 2006 Nov; 37(3):190-4. PubMed ID: 16931139
[TBL] [Abstract][Full Text] [Related]
13. [Molecular variants of human papillomavirus (HPV) types 16 and 18 in adenocarcinomas of the cervix].
Picconi MA; Alonio LV; García Carrancá A; Lizano M; Cervantes Vazquez G; Distefano AL; Mural J; Bazan G; Teyssie AR
Medicina (B Aires); 2000; 60(6):889-94. PubMed ID: 11436697
[TBL] [Abstract][Full Text] [Related]
14. Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up.
Branca M; Garbuglia AR; Benedetto A; Cappiello T; Leoncini L; Migliore G; Agarossi A; Syrjänen K;
Int J STD AIDS; 2003 Jun; 14(6):417-25. PubMed ID: 12816671
[TBL] [Abstract][Full Text] [Related]
15. High sensitivity of PCR in situ hybridization for the detection of human papillomavirus infection in uterine cervical neoplasias.
Xiao Y; Sato S; Oguchi T; Kudo K; Yokoyama Y; Saito Y
Gynecol Oncol; 2001 Aug; 82(2):350-4. PubMed ID: 11531292
[TBL] [Abstract][Full Text] [Related]
16. Multiplex nested PCR (MNP) assay for the detection of 15 high risk genotypes of human papillomavirus.
Brestovac B; Harnett GB; Smith DW; Frost F; Shellam GR
J Clin Virol; 2005 Jun; 33(2):116-22. PubMed ID: 15911426
[TBL] [Abstract][Full Text] [Related]
17. Identification of H, K, and N-ras point mutations in stage IB cervical carcinoma.
Grendys EC; Barnes WA; Weitzel J; Sparkowski J; Schlegel R
Gynecol Oncol; 1997 May; 65(2):343-7. PubMed ID: 9159349
[TBL] [Abstract][Full Text] [Related]
18. [Study of the association between human papillomavirus infection and cervical cancer in Xianguan county, Shanxi province].
Zhao F; Li N; Ma J
Zhonghua Liu Xing Bing Xue Za Zhi; 2001 Oct; 22(5):375-8. PubMed ID: 11769697
[TBL] [Abstract][Full Text] [Related]
19. Comparisons of HPV DNA detection by MY09/11 PCR methods.
Castle PE; Schiffman M; Gravitt PE; Kendall H; Fishman S; Dong H; Hildesheim A; Herrero R; Bratti MC; Sherman ME; Lorincz A; Schussler JE; Burk RD
J Med Virol; 2002 Nov; 68(3):417-23. PubMed ID: 12226831
[TBL] [Abstract][Full Text] [Related]
20. Detection and genotyping of human papillomavirus DNA by SPF10 and MY09/11 primers in cervical cells taken from women attending a colposcopy clinic.
Perrons C; Kleter B; Jelley R; Jalal H; Quint W; Tedder R
J Med Virol; 2002 Jun; 67(2):246-52. PubMed ID: 11992586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
